Applications of 1-Bromo-3-Chloro-2-Methylpropane in Industrial Manufacturing

1-Bromo-3-Chloro-2-Methylpropane serves as a specialized halogenated intermediate in organic synthesis. Its unique substitution pattern yields predetermined reactivity valuable to select industries. As an original manufacturer, we enable our partners’ advanced formulations and controlled industrial processes by supplying this raw material with full batch traceability and documentation. Below are several real-world downstream application scenarios where this compound contributes functionally and in compliance with rigorous industry protocols.

1. Agrochemical Intermediate Synthesis for Herbicide Formulation

This material acts as a pivotal building block in producing specific substituted pyridine or phenoxy compounds used in herbicide active ingredients. Agrochemical sector formulators employ it for its precise balance of reactivity and halogen incorporation, supporting high selectivity during C–C and C–N coupling stages. Application focus targets resistance management in crop protection, with downstream partners emphasizing traceable sourcing and adherence to responsible care policies.

Industry compliance standards

• FAO/WHO Specifications (FAO/WHO, Joint Meeting on Pesticide Specifications)
• ISO 9001:2015 Quality Management Systems
• REACH (EC) No 1907/2006 Registration for intermediates
• Sustainable Use of Pesticides Directive (2009/128/EC) for the EU market

Typical usage ratio

• Typically 0.5–2.0 molar equivalents to target ring system; precise scale adjusted per intended yields and downstream conversion efficiency data.

Downstream process integration

• Added during staged nucleophilic substitution or alkylation steps at controlled temperature and pressure prior to post-reaction workup. Timing calibrated for full intermediate conversion.

Final product types

• Selective herbicide active ingredients for cereals and horticultural crops
• Pre-emergence weed control granules
• Suspension concentrate formulations for commercial application
• Water-dispersible granule packs

2. Pharmaceutical Intermediate for API Side Chain Modification

The compound is involved in multi-step syntheses of certain pharmaceutical active intermediates, especially where a halogenated branched chain functions as a key moiety for selectivity or metabolic stability. Production chemists in GMP environments rely on its high-purity supply for batch reproducibility and regulatory submission support, with close monitoring during process validation and cleaning verification to meet regulatory authority inspection expectations for trace impurities.

Industry compliance standards

• International Council for Harmonisation (ICH Q7) GMP for Active Pharmaceutical Ingredients
• United States Pharmacopeia (USP) monographs for starting materials (where specified)
• EU EudraLex Volume 4 GMP Guidelines
• FDA’s 21 CFR Parts 210 & 211 for finished drug manufacturing

Typical usage ratio

• Added in 1.05–1.20 equivalents for side chain alkylation during semi-batch or batch synthesis, optimized by pilot batch yields and impurity profile controls.

Downstream process integration

• Introduced during late-stage functionalization or protection-deprotection cycles, monitored by in-process analytical controls such as HPLC for residuals and intermediates.

Final product types

• Pharmaceutical intermediates for custom synthesis of prescription drugs
• Branched chain-containing APIs for CNS or anti-infective agents
• Pilot-scale preclinical compound lots
• Contract manufactured bulk intermediates for further downstream processing

3. Fine Chemical Building Block for Fragrance and Flavor Synthesis

Flavors and fragrance chemical houses integrate 1-Bromo-3-Chloro-2-Methylpropane for constructing certain halogenated or branched aroma molecules via controlled alkylation or substitution. Its specificity supports consistent olfactory profiles, and repeated quality validation ensures compliance with food-grade requirements when applicable.

Industry compliance standards

• IFRA (International Fragrance Association) Standards Batch Documentation
• FEMA GRAS listing considerations (Flavor and Extract Manufacturers Association, where applicable)
• EU Regulation (EC) No 1334/2008 for food flavorings
• ISO 9001:2015 for in-process QC of fine chemicals

Typical usage ratio

• Applied at 0.2–1.0 molar equivalents per target intermediate; dosage refined by target synthesis and regulatory assessment of residual halides in finished aroma or flavor compounds.

Downstream process integration

• Fed into key alkylation or Friedel–Crafts-type reactions under catalyst-mediated conditions, followed by hydrolysis and purification consistent with olfactory-value retention protocols.

Final product types

• Branched-chain aroma chemicals for perfumery
• Halogenated flavor bases for processed food applications
• Synthetic musk or woody-note molecule concentrates
• Blending stocks for formulation of complex fragrance accords

4. Specialty Polymer Intermediate in Functional Acrylic Resins

This bromochloro alkane is used in small quantities during functional modification of acrylic resin chains, imparting targeted resistance properties or introducing controlled halogen content to specialty polymers. Custom resin formulators verify raw material traceability for audits and use statistical process control for lot-to-lot consistency, prioritizing compliance with application-specific safety and emissions requirements.

Industry compliance standards

• ISO 14001:2015 Environmental Management (for low emissions)
• RoHS Directive 2011/65/EU (for electronic or automotive plastics)
• UNI EN ISO 9001 for polymer quality management
• SEMI S2 Environmental, Health, and Safety Guideline (for electronics sector resins)

Typical usage ratio

• Introduced in the range of 0.5–3% by weight of total monomer charge during pre-polymer or co-polymerization steps, determined by resin performance targets and halogen level limits in downstream regulatory dossiers.

Downstream process integration

• Dosed during in-situ reaction for chain modification under controlled temperature and stirring; integration phase followed by post-polymerization neutralization and stripping.

Final product types

• Halogen-modified acrylic coatings for electronics enclosures
• Specialty adhesives requiring flame retardancy or chemical resistance
• High-performance automotive polymer blends
• Formulated binders for specialty print and packaging applications

5. API Intermediate for Veterinary Drug Synthesis

Veterinary drug manufacturers use this halogenated intermediate in the preparation of active pharmaceutical ingredients that require enhanced metabolic stability or targeted release properties for livestock medications. Process chemists apply validated methods to control and document residual levels, aligning with industry monitoring of animal-feed and companion-animal drug purity and traceable supplier chain requirements.

Industry compliance standards

• VICH GL35 Good Manufacturing Practice for Active Pharmaceutical Ingredients (Veterinary)
• FDA Guidance for Industry: Impurities in New Veterinary Drug Substances (VICH GL10)
• European Pharmacopoeia quality standards
• ISO 9001 and 14001 for in-plant controls

Typical usage ratio

• Typically 1.15–1.35 molar equivalents per target reaction step; adjusted according to batch validation and impurity clearance data.

Downstream process integration

• Supplied during the alkylation phase prior to crystallization or salt formation for the final API; process includes in-line monitoring for trace halide removal.

Final product types

• Finished veterinary APIs for antiparasitic tablets and suspensions
• Bulk actives for livestock injectable preparations
• Feed additive active substances
• Intermediates for further downstream formulation into oral or injectable veterinary medicines